General Information of Drug (ID: DM1VJJJ)

Drug Name
Ifenprodil
Synonyms
Ifenprodil; 23210-56-2; ifenprodil tartrate; Vadilex; Dilvax; Creocral; Ifenprodil [INN:DCF]; RC 61-91; Ifenprodilum [INN-Latin]; UNII-R8OE3P6O5S; EINECS 245-491-4; R8OE3P6O5S; CHEMBL305187; IFENPRODIL HEMITARTRATE; NCGC00024643-03; Ifenprodil
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2/3 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C21H27NO2
Canonical SMILES
CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3
InChI
1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3
InChIKey
UYNVMODNBIQBMV-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
3689
ChEBI ID
CHEBI:93829
CAS Number
23210-56-2
TTD ID
D06GYY

References

1 ClinicalTrials.gov (NCT04382924) Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Confirmed COVID-19 Infected Hospitalized Patients. U.S. National Institutes of Health.